About our research
Our lab is dedicated to uncovering how genetic mutations associated with neurodevelopmental disorders disrupt brain function.
Our ultimate goal is to bridge the gap between genetic mutations, synaptic and circuit-level dysfunction, providing insights that can guide therapeutic strategies for individuals affected by these disorders.
Target Genes
- EHMT1 (Kleefstra syndrome)
- KANSL1 (Koolen-de Vries syndrome)
- CHD2 (epileptic encephalopathy and autism spectrum disorders)
- SCN1A (Dravet syndrome)
Research Focus
We focus in particular on synaptic genes and chromatinopathies, as these represent some of the most frequently mutated genes in affected individuals. Through our research, we investigate how mutations impair synaptic communication and alter network dynamics.
Methods
By leveraging the power of human stem cell biology, we create models that allow us to study disease mechanisms with high fidelity. Our experimental systems include:
Our Expertise
We have developed strong expertise in several key areas that position us as leaders in the emerging field of linking genetic mutations to functional deficits in human neuronal networks:
Generating patient-derived neural lineages from human stem cells
Analyzing neurophysiological properties at both single-cell and network levels
Multi-electrode array (MEA) technology for comprehensive network analysis
Disease modeling with high fidelity to human neuro-development